Tiazofurine

Revision as of 16:42, 14 April 2015 by Turky Alkathery (talk | contribs) (Created page with " {{Drugbox | verifiedrevid = 444227977 | IUPAC_name = (1''R'')-1-[4-(aminocarbonyl)-1,3-thiazol-2-yl]-1,4-anhydro-<small>D</small>-ribitol | image = Tiazofurin.svg <!--Clinic...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Tiazofurine
File:Tiazofurin.svg
Clinical data
Synonyms2-[(2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-thiazole-4-carboxamide
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC9H12N2O5S
Molar mass260.268 g/mol
3D model (JSmol)
  (verify)

Tiazofurin is an inhibitor of IMP dehydrogenase. Tiazofurin and its analogues are under investigation for potential use in the treatment of cancer.[1]

References

  1. Popsavin M, Torović L, Svircev M; et al. (2006). "Synthesis and antiproliferative activity of two new tiazofurin analogues with 2'-amido functionalities". Bioorg. Med. Chem. Lett. 16 (10): 2773–6. doi:10.1016/j.bmcl.2006.02.001. PMID 16495053.

Template:Intracellular chemotherapeutic agents


Template:Antineoplastic-drug-stub